Cross Country Healthcare (CCRN) Post Q2 Loss of $0.10/Share

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of ($0.10), which may note compare the analyst estimate of $0.01. Revenue for the quarter came in at $122.7 million versus the consensus estimate of $122.79 million.

Issued third Quarter Guidance: Revenue of $187.0 million - $192.0 million and Adjusted EBITDA margin of 3.0% - 3.5%

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30